House Bill 4553
116th Congress(2019-2020)
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
Introduced
Introduced in House on Sep 27, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4553
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
September 27, 2019
09/30/2019
Referred to the Subcommittee on Health.
09/27/2019
Referred to the House Committee on Energy and Commerce.
09/27/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:45 PM